‹ All Posts
Naveen Kumar

28th Mar · SEBI-Registered Analyst

NATCOPHARM

Natco Pharma's board has approved a demerger plan, separating its Agrochemicals business into a new entity called Natco Crop Health Sciences. This strategic move aims to unlock value by allowing each business vertical to focus on its core competencies. The demerger is expected to improve operational clarity and potentially attract investors specific to the pharma and agrochemical sectors. This restructuring could lead to better valuation multiples for both entities in the future.

#WatchOutFor#MacroViews#EquityResearch#Miscellaneous#PersonalFinance
866 likes·61 comments